A b s t r a c t
Streptomyces species are gram-positive filamentous bacteria and soil inhabitants. They are well known for production of antibiotics as secondary metabolites. Although these organisms may be isolated from various clinical specimens, they rarely represent true infections, particularly in a polymicrobial setting. Streptomyces may cause mycetoma; when it occurs in a lower extremity, it is known as Madura foot. Mycetoma involves soft tissue and bone and is characterized by tumefaction and draining sinuses. 1, 2 Invasive infections other than mycetomas caused by Streptomyces species are rarely encountered in clinical practice. We describe 6 cases of invasive Streptomyces infections and review 13 other cases reported in the literature.
Materials and Methods
The microbiology culture records of The University of Texas M.D. Anderson Cancer Center, Houston, a 500-bed tertiary care cancer hospital, were searched electronically to identify isolates of Streptomyces species from sterile specimens or sites from January 1997 to December 2005. The medical records of the patients were reviewed to assess clinical significance of the isolates. Most organisms were isolated from blood cultures using the BACTEC 9240 automated culturing system (BD Diagnostic Systems, Sparks, MD) and the Isolator lysis centrifugation method (Wampole Laboratories, Princeton, NJ). A positive culture from the Isolator included quantitation of the organism in 10 mL of blood cultured. Antibiotic susceptibility testing, when performed, was done at a reference laboratory (Focus Technologies, Cypress, CA). Several recent Streptomyces isolates were identified to the species level, or most closely resembling (MCR), by using a method to amplify and sequence the 16S ribosomal RNA gene that was described previously. 3 Published cases of nonmycetomic invasive Streptomyces infections were identified by a literature search of the PubMed database. In addition, references to past case reports that were identified in any of the reviewed articles, but not found in the PubMed literature search, were obtained and included in our literature review.
Results
During the 9 years (1997-2005) studied in our institution, a total of 47 patients had positive cultures for Streptomyces species in sterile specimens or sites. Of these patients, 6 (13%) were found to represent true Streptomyces infections, whereas in other cases, the organism was considered a contaminant. The contaminant was usually a single colony from the Isolator blood cultures. The 6 cases of infections are summarized in ❚Table 1❚ and described briefly as follows.
Case 1
Pleuritic chest pain developed in a 21-year-old chronically neutropenic woman with refractory acute myelogenous leukemia treated with cytarabine and fludarabine. A computed tomography (CT) scan of the chest revealed multiple lung nodules with the largest (2.5 cm) being pleura-based in the right lower lobe ❚Image 1A❚, suggesting fungal infection. After failure to respond to 2 months of liposomal amphotericin B and caspofungin, a fine-needle aspiration was performed, revealing a mesh of Streptomyces on a necro-inflammatory background ❚Image 1B❚ that was highlighted well on a Gomori methenamine silver stain as thin hyphae-like filaments ❚Image 1C❚. The organism grew in mycobacteriologic culture after 8 days and was identified as Streptomyces maritimus or Streptomyces olivaceus (MCR, matching 631 of 632 nucleotides).
Initial therapy with minocycline and intravenous ceftriaxone was begun after the histopathologic findings were available. Further testing revealed that the organism was susceptible to clarithromycin and amikacin but resistant to an amoxicillin-clavulanate combination, ceftriaxone, ciprofloxacin, imipenem, and a trimethoprim-sulfamethoxazole combination (TMP/SMZ). Owing to a lack of clinical improvement and the results of susceptibility testing, ceftriaxone was stopped. Clarithromycin and moxifloxacin were added, along with minocycline. However, 2 months after the initial diagnosis of the Streptomyces infection, the patient died of refractory leukemia.
Case 2
The patient was a 23-year-old woman with a history of systemic lupus erythematosus and intermittent corticosteroid therapy. A right lung nodule was noted incidentally on a chest radiograph with associated hilar and mediastinal lymphadenopathies, but the patient was asymptomatic.
An excisional biopsy was performed. Histopathologic examination showed necrosis and granulomatous reactions, and a few dispersed gram-positive rods were seen in the lesion. Cultures grew Streptomyces albus (MCR, matching 315 of 318 nucleotides owing to sequencing difficulty) that was bacillary in early culture and turned filamentous later. The organism was susceptible to amikacin, amoxicillin-clavulanate, imipenem, and TMP/SMZ but resistant to ceftriaxone, ciprofloxacin, clarithromycin, and minocycline. No antibiotic therapy was given because the nodule was excised and the patient was asymptomatic. At 5 months after the excision, the patient was doing well clinically, and a chest CT scan revealed an improvement in the previous lymphadenopathy. 
Case 3
A 71-year-old man with metastatic cholangiocarcinoma was admitted to the emergency department with subjective fever and dyspnea for a day. The patient had been receiving gemcitabine and cisplatin chemotherapy with the last dose 4 days earlier, but he had not been neutropenic. A chest radiograph showed bilateral pleural effusions. Blood cultures were obtained from a peripheral vein and a central venous catheter (CVC). Pleural fluid cultures were also obtained. He was treated initially with empiric piperacillin-tazobactam and azithromycin and admitted to the hospital.
The blood cultures became positive at day 2 for 101 to 200 colonies (from 10 mL of blood cultured) of a filamentous gram-positive bacterium from CVC and 51 to 100 colonies peripherally. The organism was negative for partial acid-fast stain and was identified as Streptomyces (MCR Streptomyces nobilis or Streptomyces parvulus, matching 572 of 572 nucleotides). The CVC was removed, and culture of the tip was negative. The pleural effusions were found to be malignant without organisms. The patient was treated with azithromycin and other antibiotics during the admission and did well clinically.
The organism was tested and found to be susceptible to clarithromycin, minocycline, amikacin, amoxicillin-clavulanate, imipenem, and TMP/SMZ; intermediately susceptible to ceftriaxone; and resistant to ciprofloxacin. The patient was discharged with prescriptions for 2 months of minocycline and 6 months of azithromycin; the infection did not recur.
Case 4
This patient, a 51-year-old woman who had a history of breast cancer with metastases to the liver and brain and had been receiving trastuzumab, developed rigors and nonneutropenic fevers (up to 39.4°C) following flushing of her CVC. Cultures of the CVC blood became positive after 3 days for 51 to 100 colonies of Streptomyces (MCR Streptomyces humidus or Streptomyces pilosus, matching 568 of 568 nucleotides), but no peripheral blood cultures were obtained. Susceptibility testing was not done. After CVC removal, the patient's symptoms and signs resolved. Thus, this case also represented a catheter-related bloodstream infection.
Case 5
A 25-year old-man with a history of Ewing sarcoma of the left superior pubic ramus and acetabulum developed neutropenic fever (38.3°C). He had received antineoplastic chemotherapy consisting of vincristine, doxorubicin, and ifosfamide 2 weeks earlier. Blood cultures obtained from the CVC revealed 201 to 500 colonies of coagulase-negative Staphylococcus and 201 to 500 colonies of Streptomyces (MCR Streptomyces indigoferus or Streptomyces herbaricolor, matching 576 of 577 nucleotides). Peripheral blood cultures were negative. No susceptibility testing was done on the Streptomyces organism.
The patient was treated empirically with gatifloxacin at the onset of fever. The fever abated soon, and his CVC was removed a few days later. Repeated blood cultures were negative. The presence of a high Streptomyces colony count and fevers also makes this case a catheter-related infection.
Case 6
This patient was an 18-year-old man with a history of Burkitt lymphoma and recently completed antineoplastic chemotherapy that lasted for 6 months and consisted of methotrexate, rituximab, cytarabine, and others. He had a new left upper lobe cavitary lesion and numerous new, smaller than 2 mm lung nodules that were detected by chest CT scan. Small bilateral lung nodules had been noted on the initial chest CT scan performed as part of the lymphoma work-up, but he was asymptomatic then and not treated. This time, the patient had a cough and blood eosinophilia. Culture of a bronchoalveolar lavage specimen grew a Penicillium species, leading to treatment with voriconazole. However, the lung nodules progressed despite voriconazole treatment. Owing to the development of a skin rash and persistent eosinophilia, voriconazole was discontinued. The pulmonary nodules waxed and waned for 9 months, which prompted an open lung biopsy to excise the 2 largest nodules. Pathologic examination revealed vague granulomas with eosinophils and intra-alveolar macrophages but negative Gomori methenamine silver, acid-fast bacillus, and Gram stains. Cultures later grew a Streptomyces species from the left upper lobe cavitary lesion. (The species was not identified.)
At several follow-up visits within a year after surgery, other pulmonary nodules continued to have a remittingrelapsing course. However, the patient had no major symptoms and did not require steroid therapy. Thus, the lung nodules could represent toxicity from methotrexate therapy, a known entity, 4 or possible hypersensitivity pneumonitis caused by the Streptomyces, which has also been reported, [5] [6] [7] or both.
Discussion and Literature Review
The ubiquitous nature and the low pathogenicity of Streptomyces organisms make most clinical isolates contaminants or colonizers. As such, most clinical microbiology laboratories offer presumptive identification of Streptomyces species, ie, long filamentous gram-positive bacteria that grow aerobically and are negative for partial acid-fast stain. These features distinguish Streptomyces species from other morphologically similar genera within Actinomycetales, ie, anaerobic Actinomycetes, and aerobic Nocardia and Rhodococcus that are usually partially acid-fast. In our experience, cultured Streptomyces can be likened to a hairball or a mesh of filaments, also differing from Actinomyces, Nocardia, and Rhodococcus.
On the clinical side, it is difficult to diagnose Streptomyces infections definitively, and a stringent clinical and microbiologic correlation is needed in this regard, such as clinical manifestations, isolation of the organism from sterile sources (ideally in large quantities), direct microscopic identification in infected tissue, and exclusion of other causes. By using combinations of at least 2 of these criteria, we found in this study that 13% (6/47) of Streptomyces isolates, almost all from immunocompromised cancer patients, represented true infections. There were 3 CVCrelated bloodstream infections and 3 lung infections. None of the cases resembled Streptomyces mycetoma. In view of the difficulty in accurately identifying the vast number of Streptomyces species (>200 species), the 5 species identified by 16S ribosomal RNA gene sequencing were considered at best to be presumptive species identifications. No single species was seen, consistent with the highly opportunistic nature of the infections.
In the literature reported since 1951, we located 18 cases of nonmycetomic invasive Streptomyces infections ❚Table 2❚. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Of note, the 5 cases reported from Nigeria (cases 8-12) did not meet our stringent diagnostic criteria because the patients, all male farmers with hemoptysis and chest pain, had Streptomyces isolated from nonsterile sputum samples only. The remaining 13 cases were all caused or contributed to by Streptomyces organisms, and bacteremia and lung infections (abscess formation, pneumonitis, and pneumonia) accounted for most of them. At least 5 Streptomyces species were involved, all differing from our species, and we believe these are also presumptive identifications. The infections were not localized to any particular geographic region, unlike Streptomyces mycetomas that are more prevalent in certain parts of Africa and Asia. 2 All of the remaining 8 cases since 1985 had underlying conditions: 4 with AIDS or HIV infection, 2 with cancer, 1 with a prosthetic heart valve, and 1 with Crohn disease. No deaths were fully attributed to Streptomyces.
❚Table 3❚ shows available antibiotic susceptibility data from case studies of various Streptomyces species and a study of Streptomyces griseus. 22 All tested organisms were susceptible to amikacin, and most were also susceptible to imipenem, clarithromycin, erythromycin, amoxicillin-clavulanate, and TMP/SMZ. In contrast, few strains were susceptible to ceftriaxone, ciprofloxacin, and ampicillin. These results should provide valuable guidance for empiric coverage while awaiting strain-specific susceptibility data.
The small number of Streptomyces infections has limited the clinical experience with the management of these illnesses. We are unable to discern any patterns of treatment in terms of the choice of antibiotics and length of therapy for our cases or for the cases reported in literature. Clinical situations, such as host immune status, location and chronicity of infection, and response to treatment, will likely dictate the approach of intervention. Because CVC catheters were all removed on culture positivity in our 3 cases and all 3 cases in the recent literature also had positive cultures in fewer than 4 days, [19] [20] [21] it is uncertain whether CVC removal is required to clear the CVC-related bloodstream infection. There were no secondary lesions caused by bloodstream dissemination in these cases. 
